Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Myeloid 1

Conditions

Breast Neoplasms 3Polycystic Ovary Syndrome 2Obesity 2Neoplasms 2Motor Activity 2Feeding Behavior 2Cardiovascular Diseases 2Thyroid Neoplasms 1Thrombocythemia, Essential 1Primary Myelofibrosis 1Polycythemia Vera 1Overweight 1Neuroendocrine Tumors 1Myocardial Infarction 1Myeloproliferative Disorders 1Multiple Endocrine Neoplasia Type 1 1Metabolic Syndrome 1Intermittent Fasting 1Inflammation 1Hereditary Breast and Ovarian Cancer Syndrome 1Diabetes Mellitus 1Cognitive Dysfunction 1Angina, Unstable 1

Interventions

Exercise 5Vitamin D 2Tea 2Sufentanil 2Spironolactone 2Probiotics 2Oxycodone 2Omeprazole 2Morphine 2Metformin 2Etanercept 2Colchicine 2Ascorbic Acid 2ziprasidone 1soybean oil, phospholipid emulsion 1salicylsalicylic acid 1ginger extract 1falcarinol 1falcarindiol 1epigallocatechin gallate 1Zolpidem 1Warfarin 1Vecuronium Bromide 1Vancomycin 1Tumor Necrosis Factors 1Tranexamic Acid 1Tobramycin 1Sulindac 1Sodium Salicylate 1Sodium Chloride 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Inflammation × Diet, Mediterranean × Clear all
NCT03907436 2020-03-24

NUTRIENT

University of California, Irvine

Phase NA Completed
30 enrolled
Myeloid

Inflammation, Myeloproliferative Disorders, Polycythemia Vera, Thrombocythemia, Essential, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡